Deepflare

Deepflare is a techbio AI company helping pharma firms in cancer vaccine and immunotherapy development via an ML model suite. The model predicts T-cell responses and identifies key epitopes, enhancing antigen immunogenicity. This approach validated through partnerships, speeds up pre-clinical research by 4x more compared to leading ML models used in the market, reduces costs, and improves vaccine efficacy.

Deepflare is unique in the industry as it offers an advanced computational platform that can analyze immunopeptidomics data and identify potential neoantigens for personalized cancer therapies, assess immunogenic potential, and integrate laboratory automation systems to accelerate the drug development process.

The company was established by a team of an ML researcher, a clinician, and a go-to-market specialist with a strategic consulting background. They are also supported by seasoned advisors from Pfizer and Moderna.